PD17-06 RANDOMIZED PHASE II TRIAL OF INTRAVESICAL ADENOVIRAL MEDIATED INTERFERON-α GENE THERAPY WITH THE EXCIPIENT SYN3 (RAD-IFNα/SYN3) IN PATIENTS WITH BCG REFRACTORY OR RELAPSING HIGH GRADE (HG) NON MUSCLE INVASIVE BLADDER CANCER (NMIBC)

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Canter, D; Boorjian, S; Ogan, K; Shore, N; Bivalacqua, T; Bochner, B; Downs, T; Gomella, L; Grubb, R; Inman, B; Kamat, A; Karsh, L; Krupski, T; Lerner, S; Lotan, Y; Milowsky, M; Schoenberg, M; Svatek, R; Woods, M; Dinney, C

Published Date

  • April 2015

Published In

Volume / Issue

  • 193 / 4S

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-3792

International Standard Serial Number (ISSN)

  • 0022-5347

Digital Object Identifier (DOI)

  • 10.1016/j.juro.2015.02.663